Miramar Labs gets $20M for “aesthetic” devices

Miramar Labs (no Web site), a Menlo Park, Calif., medical-device maker, raised $20.3 million in a second funding round, I’ve learned. There isn’t a huge amount of public information about the company, although it appears that the company is working on electromechanical devices of some… Continue Reading

Life sciences briefing: Friday, Jan. 18, 2007

Life sciences briefing: Friday, Jan. 18, 2007

TODAY’S HEADLINES:

Ulthera receives $23M for cosmetic ultrasound devices (release)
Senexis raises £2.9M for Alzheimer’s drugs (PDF release)
Elixir Pharma postpones IPO (IPO Home)
Cancer Therapeutics names Randall Riggs as CEO (release)

Ulthera receives $23M for cosmetic ultrasound devices — Ulthera, a Mesa, Ariz., startup developing ultrasound systems for cosmetic… Continue Reading

Life sciences briefing: Wednesday, Jan. 2, 2008

Life sciences briefing: Wednesday, Jan. 2, 2008

TODAY’S HEADLINES:

Israel’s Alma Lasers files for $86M IPO (Edgar)
Allscripts acquires hospital-management software co. ECIN for $90M (release)
AgaMatrix, glucose-sensor maker, raises $24M (PE Hub)

Israel’s Alma Lasers files for $86M IPO — Alma Lasers, an Israeli maker of lasers for cosmetic procedures, filed to raise $86.3 million… Continue Reading

Life sciences briefing: Monday, Oct. 29, 2007

Life sciences briefing: Monday, Oct. 29, 2007

Featured companies: Azaya Therapeutics, Global Care Solutions, Oxford Immunotec, RealSelf.com, Sequoia Pharmaceuticals, Tactile Systems Technology, WellGen, Zeltiq Aesthetics

UPDATED: Expanded items on Oxford Immunotec, Zeltiq, Tactile Systems, RealSelf.com and Global Care.

Oxford Immunotec pulls in $40M for TB tests — Oxford Immunotec, a U.K. biotech focused on new diagnostic… Continue Reading

Life sciences briefing: Monday, Oct. 22, 2007

Life sciences briefing: Monday, Oct. 22, 2007

Featured companies: Ablynx, Avant Immunotherapeutics, BioForm Medical, Celldex Therapeutics, Genomas, High-Throughput Genomics, Orchid Cellmark, ReliaGene Technologies, SarCode, TransMolecular, VisEn Medical

UPDATED: Expanded items on SarCode, Celldex/Avant and Ablynx.
UPDATE REDUX: Added items on BioForm Medical, High-Throughput Genomics and Orchid Cellmark/ReliaGene.

San Francisco’s SarCode draws down $7M for inflammation drugs — The… Continue Reading

Life sciences briefing: Wednesday, Sept. 5, 2007

Life sciences briefing: Wednesday, Sept. 5, 2007

Featured companies: Atritech, Avalon Partners, Ensemble Discovery, Hyperion Therapeutics, LifeBond, ReShape Medical, SafeStitch, Trophos, UltraShape

Hyperion Therapeutics raises $40M against GI and kidney disease — Hyperion Therapeutics, a South San Francisco, Calif., specialty pharmaceutical company, raised $40 million in a second funding round. Investors included Sofinnova Ventures,… Continue Reading

Life sciences briefing: Tuesday, Aug. 21, 2007

Life sciences briefing: Tuesday, Aug. 21, 2007

(UPDATED at 7:40pm PT: See below.)

Featured companies: Adnexus Therapeutics, BioForm Medical, Confirma, Cardiovascular Systems, Mirabilis Medica, Neuromed Pharmaceuticals, PlaCor, Seno Medical Instruments, Vibrynt

BioForm Medical files $115M IPO for “medical aesthetics” — BioForm Medical, a San Mateo, Calif., developer of wrinkle fillers and other products for… Continue Reading